This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:SaraKathryn Kalkhoff/Sandbox 1
From Proteopedia
(Difference between revisions)
| Line 9: | Line 9: | ||
The GIP receptor helps facilitate movement of glucose within a cell. <ref name='Sun'>PMID:35333651</ref>. | The GIP receptor helps facilitate movement of glucose within a cell. <ref name='Sun'>PMID:35333651</ref>. | ||
===Tirzepatide=== | ===Tirzepatide=== | ||
| - | Tirzepatide has been used as a treatment for Type 2 diabetes. | + | Tirzepatide has been used as a treatment for Type 2 diabetes. It has 39 total residues. |
| + | <scene name='10/1037492/Tirz/3'>Tirzepatide structure</scene> | ||
== Disease == | == Disease == | ||
Diabetes is very bad for you<ref name='Ransey'>PMID:28504306</ref>. | Diabetes is very bad for you<ref name='Ransey'>PMID:28504306</ref>. | ||
Revision as of 14:34, 26 March 2024
Glucose-Dependent Insulinotropic Receptor/GIPR bound with Tirzepatide
| |||||||||||
